Valuation: Abbott India Limited

Market Cap 593B 6.22B 5.4B 5.05B 4.62B 8.73B 8.84B 59.13B 23.21B 296B 23.36B 22.85B 985B P/E 2027 *
34.7x
P/E 2028 * 30.9x
Enterprise Value 569B 5.97B 5.18B 4.85B 4.44B 8.38B 8.49B 56.75B 22.27B 284B 22.42B 21.93B 946B EV / Sales 2027 *
7.57x
EV / Sales 2028 * 6.88x
Free-Float
24.46%
Yield 2027 *
2.07%
Yield 2028 * 2.23%
1 day-0.67%
1 week-0.30%
Current month-0.30%
1 month+3.70%
3 months+3.78%
6 months+0.81%
Current year-4.71%
1 week 27,665
Extreme 27665
28,162.45
1 month 26,110.75
Extreme 26110.75
29,250
Current year 25,164
Extreme 25164
29,250
1 year 25,164
Extreme 25164
34,035
3 years 21,907.45
Extreme 21907.45
35,921.55
5 years 15,525
Extreme 15525
35,921.55
10 years 3,996
Extreme 3996
35,921.55
Manager TitleAgeSince
Chief Executive Officer 46 2025-06-13
Director of Finance/CFO 52 2025-05-05
Director of Finance/CFO - 2025-03-31
Director TitleAgeSince
Chairman 83 1967-12-31
Director/Board Member 69 2011-02-28
Director/Board Member 71 2019-03-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%-0.30%-15.46%+15.66% 6.22B
+1.89%+3.20%+59.70%+165.18% 1,062B
-0.24%+0.45%+50.64%+52.02% 619B
-0.95%-5.26%+24.23%+65.08% 431B
+2.07%+3.20%+46.70%+37.60% 358B
+0.93%-1.26%+35.52%+40.54% 293B
+1.02%-6.84%+7.20%+8.62% 247B
-0.73%+4.44%+42.22%+66.41% 219B
+3.13%-11.27%+1.42%-44.69% 200B
-0.68%-0.32%+18.66%+66.32% 162B
Average +0.25%-1.59%+27.08%+47.27% 359.85B
Weighted average by Cap. +0.02%-0.82%+40.74%+77.72%

Financials

2027 *2028 *
Net sales 75.09B 788M 684M 641M 586M 1.11B 1.12B 7.49B 2.94B 37.52B 2.96B 2.9B 125B 82.25B 863M 749M 702M 642M 1.21B 1.23B 8.21B 3.22B 41.09B 3.24B 3.17B 137B
Net income 17.05B 179M 155M 145M 133M 251M 255M 1.7B 668M 8.52B 672M 658M 28.36B 19.12B 201M 174M 163M 149M 282M 285M 1.91B 749M 9.55B 754M 737M 31.79B
Net Debt -23.86B -250M -217M -204M -186M -351M -356M -2.38B -934M -11.92B -940M -920M -39.67B -26.92B -283M -245M -230M -210M -397M -402M -2.69B -1.05B -13.45B -1.06B -1.04B -44.77B
Logo Abbott India Limited
Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.
Employees
3,679
Date Price Change Volume
26-08-07 27,700.00 -0.67% 173
26-08-06 ₹27,885.85 +0.55% 272
26-08-05 ₹27,733.40 -0.40% 626
26-08-04 ₹27,845.85 -0.07% 168
26-08-03 ₹27,866.30 +0.30% 560
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBOTINDIA Stock